Debomoy K. Lahiri
Affiliations: | Medical Neurobiology | Indiana University, Bloomington, Bloomington, IN, United States |
Area:
Neuroscience Biology, Cell Biology, Molecular BiologyGoogle:
"Debomoy Lahiri"Mean distance: 53433
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Schmued L, Maloney B, Schmued C, et al. (2023) Treatment with 1, 10 Phenanthroline-5-Amine Reduced Amyloid Burden in a Mouse Model of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad |
| Westmark CJ, Maloney B, Alisch RS, et al. (2020) FMRP Regulates the Nuclear Export of Adam9 and Psen1 mRNAs: Secondary Analysis of an N-Methyladenosine Dataset. Scientific Reports. 10: 10781 |
| Dorszewska J, Lahiri DK. (2020) Diversity of Molecular Factors in Alzheimer's Disease. Current Alzheimer Research. 17: 205-207 |
| Ray B, Maloney B, Sambamurti K, et al. (2020) Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's disease. Translational Psychiatry. 10: 81 |
| Ray B, Maloney B, Sambamurti K, et al. (2020) Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's disease. Translational Psychiatry. 10: 47 |
| Chopra N, Wang R, Maloney B, et al. (2020) MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties. Molecular Psychiatry |
| Maloney B, Balaraman Y, Liu Y, et al. (2019) Lithium alters expression of RNAs in a type-specific manner in differentiated human neuroblastoma neuronal cultures, including specific genes involved in Alzheimer's disease. Scientific Reports. 9: 18261 |
| Niculescu AB, Le-Niculescu H, Roseberry K, et al. (2019) Blood biomarkers for memory: toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs. Molecular Psychiatry |
| Lahiri DK. (2019) Lessons from Alzheimer's Disease (AD) Clinical Trials: Instead of "A-Drug", AD-D prevention to Avert AD. Current Alzheimer Research. 16: 279-280 |
| Sokol DK, Maloney B, Westmark CJ, et al. (2019) Novel Contribution of Secreted Amyloid-β Precursor Protein to White Matter Brain Enlargement in Autism Spectrum Disorder. Frontiers in Psychiatry. 10: 165 |